Пол Оффит - Ящик Пандоры. Семь историй о том, как наука может приносить нам вред

В конце концов, хотя и держимся за надежду на лучшую жизнь, которую нам даст наука, мы должны подходить ко всем научным достижениям осторожно и с широко открытыми глазами, убедившись, что умеем учиться на своих ошибках и они не приводят нас в ступор.

Я хочу поблагодарить Сьюзан Хичкок из National Geographic за терпение и верную руку, за то, что направляла меня в нужную сторону во время работы над книгой; также Луиса Белла, Джеффри Бергельсона, Дэвида Горски, Шарлотту Мозер, Брайана Фишера, Уилла Оффита, Бонни Оффит, Сэлли Сейтел и Лору Велла за внимательное прочтение рукописи.

Grant, John. Discarded Science: Ideas That Seemed Good at the Time. Surrey, England: Facts, Figures & Fun, 2006.

Grant, John. Corrupted Science: Fraud, Ideology, and Politics in Science. Surrey, England: Facts, Figures & Fun, 2008.

Grant, John. Bogus Science: Or, Some People Really Believe These Things. Surrey, England: Facts, Figures & Fun, 2009.

Livio, M. Brilliant Blunders: From Darwin to Einstein — Colossal Mistakes by Great Scientists That Changed Our Understanding of Life and the Universe. New York: Simon & Schuster, 2013.

Adams, Taite. Opiate Addiction: The Painkiller Addiction Epidemic, Heroin Addiction and the Way Out. Petersburg, Florida: Rapid Response Press, 2013.

Anonymous. «Closing Arguments Made in Trial of Doctor in OxyContin Deaths,» New York Times , February 19, 2002.

Anonymous. «Doctor Given Long Prison Term for 4 Deaths Tied to OxyContin,» New York Times , March 23, 2002.

Ballantyne, J. C., and J. Mao. «Opioid Therapy for Chronic Pain,» New England Journal of Medicine 349 (2003): 1943–1953.

Belluck, P. «Methadone, Once the Way Out, Suddenly Grows as a Killer Drug,» New York Times , February 9, 2003.

Booth, Martin. Opium: A History . London: Simon & Schuster, 1996.

Brownstein, M. J. «A Brief History of Opiates, Opioid Peptides, and Opioid Receptors,» Proceedings of the National Academy of Sciences 90 (1993): 5391–5393.

Califf, R. M., J. Woodcock, and S. Ostroff, «A Proactive Response to Prescription Opioid Abuse,» New England Journal of Medicine 374 (2016): 1480–1485.

Carise, D., K. L. Dugosh, A. T. McLellan, et al. «Prescription OxyContin Abuse Among Patients Entering Addiction Treatment,» American Journal of Psychiatry 164 (2007): 1750–1756.

Catan, Thomas, and Evan Perez. «A Pain-Drug Champion Has Second Thoughts,» Wall Street Journal , December 17, 2012.

Centers for Disease Control and Prevention. «Prescription Painkiller Overdoses in the US,» www.cdc.gov/vitalsigns/painkilleroverdoses, 2012.

Centers for Disease Control and Prevention. «CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016,» Morbidity and Mortality Weekly Report 65 (2016): 1–49.

Cicero, T. J., M. S. Ellis, and H. L. Surratt. «Effect of Abuse-Deterrent Formulation of Oxycontin,» New England Journal of Medicine 367 (2012): 187–189.

Clines, F. X., and B. Meier. «Cancer Painkillers Pose New Abuse Threat,» New York Times , February 9, 2001.

Courtwright, David T. Dark Paradise: A History of Opiate Addiction in America . Cambridge: Harvard University Press, 2001.

Courtwright, D. T. «Preventing and Treating Narcotic Addiction — A Century of Federal Drug Control,» New England Journal of Medicine 373 (2015): 2095–2097.

Dormandy, Thomas. Opium: Reality’s Dark Dream . New Haven: Yale University Press, 2012.

Fernandez, Humberto, and Therissa A. Libby. Heroin: Its History, Pharmacology, and Treatment . Center City, Minnesota: Hazelden, 2011.

Flascha, Carlo. «On Opium: Its History, Legacy and Cultural Benefits,» Prospect Journal , May 25, 2011.

Frakt, Austin. «Dealing With Opioid Abuse Would Pay for Itself,» New York Times , August 4, 2014.

Frankenburg, Frances R. Brain-Robbers: How Alcohol, Cocaine, Nicotine, and Opiates Have Changed Human History. Santa Barbara, California: Praeger, 2014.

Frazier, I. «The Antidote,» The New Yorker , September 8, 2014.

Grattan, A., M. D. Sullivan, K. W. Saunders, et al. «Depression and Prescription Opioid Misuse Among Chronic Opioid Therapy Recipients with No History of Substance Abuse,» Annals of Family Medicine 10 (2012): 304–311.

Harris, Nancy. Opiates . Farmington Hills, Michigan: Greenhaven Press, 2005.

Jayawant, S. S., and R. Balkrishnan. «The Controversy Surrounding OxyContin Abuse: Issues and Solutions,» Therapeutics and Clinical Risk Management 1 (2005): 77–82.

Katz, D. A., and L. R. Hays. «Adolescent OxyContin Abuse,» Journal of the Academy of Adolescent Psychiatry 43 (2004): 231–234.

Kolata, G., and S. Cohen. «Drug Overdoses Propel Rise in Mortality Rates in Young Whites,» New York Times , January 16, 2016.

Meier, B. «Overdoses of Painkiller Are Linked to 282 Deaths,» New York Times , October 28, 2001.

Meier, B. «At Painkiller Trouble Spot, Signs Seen as Alarming Didn’t Alarm Drug’s Maker,» New York Times , December 10, 2001.

Meier, B. «Official Faults Drug Company for Marketing of Its Painkiller,» New York Times , December 12, 2001.

Meier, B. «Doctor to Face U. S. Charges in Drug Case,» New York Times , December 23, 2001.

Meier, B. «OxyContin Prescribers Face Charges in Fatal Overdoses,» New York Times , January 19, 2002.

Meier, B. «A Small-Town Clinic Looms Large as a Top Source of Disputed Painkillers,» New York Times , February 10, 2002.

Meier, B. «OxyContin Deaths May Top Early Count,» New York Times , April 15, 2002.

Meier, Barry. Pain Killer: A «Wonder» Drug’s Trail of Addiction and Death. New York: Vook, 2013.

Meier, Barry. A World Full of Hurt: Fixing Pain Medicine’s Biggest Mistake . New York: The New York Times Company, 2013.

Meldrum, Marcia L. Opioids and Pain Relief: A Historical Perspective. Seattle: IASP Press, 2003.

Mundell, E. J. «FDA OK’s ‘Abuse Deterrent’ Label for New Oxycontin,» HealthDay News , April 16, 2010.

Nicolaou, K. C., and T. Montagnon. Molecules That Changed the World: A Brief History of the Art and Science of Synthesis and Its Impact on Society. Weinheim, Germany: Wiley-VCH Verlag GmbH & Co., 2008.

Paulozzi, L., G. Baldwin, G. Franklin, et al. «CDC Grand Rounds: Prescription Drug Overdoses — a U. S. Epidemic,» Morbidity and Mortality Weekly Report 61 (2012): 10–13.

Perrone, M. «U. S. Struggles to Limit Painkillers,» Philadelphia Inquirer , December 20, 2015.

Poitras, G. «Oxycontin, Prescription Opioid Abuse and Economic Medicalization,» Medicolegal and Bioethics 2 (2012): 31–43.

Portenoy, R. K., and K. M. Foley. «Chronic Use of Opioid Analgesics in Non-Malignant Pain: Report of 38 Cases,» Pain 25 (1986): 171–186.

Quinones, Sam. Dreamland: The True Tale of America’s Opiate Epidemic. New York: Bloomsbury Press, 2015.

Rosenblatt, R. A., and M. Caitlin. «Opioids for Chronic Pain: First Do No Harm,» Annals of Family Medicine 10 (2012): 300–301.

Rudd, R. A., N. Aleshire, J. E. Zibell, and R. M. Gladden. «Increases in Drug and Opioid Overdose Deaths — United States, 2000–2014,» Morbidity and Mortality Weekly Report 64 (2016): 1378–1382.

Tavernese, Sabrina. «C.D.C. Painkiller Guidelines Aim to Reduce Addiction Risk,» New York Times , March 15, 2016.

van Zee, A. «The Promotion and Marketing of OxyContin: Commercial Triumph, Public Health Tragedy,» American Journal of Public Health 99 (2009): 221–227.

Volkow, N. D., and A. T. McLellan. «Opioid Abuse in Chronic Pain — Misconceptions and Mitigation Strategies,» New England Journal of Medicine 374 (2016): 1253–1263.

Wikipedia. «Felix Hoffmann,» https://en.wikipedia.org/wiki/Felix_Hoffmann.

Zack, I. «Pain in the Asset,» Forbes , February 5, 2001.

Zweifler, J. A. «Objective Evidence of Severe Disease: Opioid Use in Chronic Pain,» Annals of Family Medicine 10 (2012): 366–368.

Aro, A., A. F. M. Kardinaal, I. Salminen, et al. «Adipose Tissue, Isomeric Trans Fatty Acids, and Risk of Myocardial Infarction in Nine Countries: The EURAMIC Study,» Lancet 345 (1995): 273–278.

Ascherio, A., C. H. Hennekens, J. E. Buring, et al. « Trans -Fatty Acids Intake and Risk of Myocardial Infarction,» Circulation 89 (1994): 94–101.

Ascherio, A., E. B. Rimm, E. L. Giovannucci, et al. «Dietary Fat and Risk of Coronary Heart Disease in Men: Cohort and Follow Up Study in the United States,» British Medical Journal 313 (1996): 84–90.

Baylin, A., E. K. Kabagambe, A. Ascherio, et al. «High 18:2 Trans-Fatty Acids in Adipose Tissue Are Associated with Increased Risk of Nonfatal Acute Myocardial Infarction in Costa Rican Adults,» Journal of Nutrition 133 (2003): 1186–1191.

Clifton, P. M., J. B. Keogh, and M. Noakes. «Trans Fatty Acids in Adipose Tissue and the Food Supply Are Associated with Myocardial Infarction,» Journal of Nutrition 134 (2004): 874–879.

Cowley, R., D. Gibson, and C. Sewell, «History of Eating in the United States: Margarine Vs. Butter,» http://historyofeating.umwblogs.org/butter.

Dijkstra, A. J., R. J. Hamilton, and W. Hamm (eds.). Trans Fatty Acids . Oxford: Blackwell Publishing, 2008.

Downs, S. M., A. M. Thow, and S. R. Leeder. «The Effectiveness of Policies for Reducing Dietary Trans Fat: A Systematic Review of the Evidence,» Bulletin of the World Health Organization 91 (2013): 262–269.

Ferdman, R. A. «The Generational Battle of Butter Vs. Margarine,» Washington Post , June 17, 2014.

Gorelick, R. «FDA Trans-Fat Ban Threatens Berger Cookies,» Baltimore Sun , November 22, 2013.

Hallock, B. «Rise and Fall of Trans Fat: A History of Partially Hydrogenated Oil,» Los Angeles Times , November 7, 2013.

Harvard University School of Public Health, «Shining the Spotlight on Trans Fats,» http://hsph.harvard.edu/nutritionsource/transfats/#big_changes.

Hu, F. B., M. J. Stampfer, J. E. Manson, et al. «Dietary Fat Intake and the Risk of Coronary Heart Disease in Women,» New England Journal of Medicine 337 (1997): 1491–1499.

Katan, M. B., P. L. Zock, and R. P. Mensink. «Trans Fatty Acids and Their Effects on Lipoproteins in Humans,» Annual Reviews of Nutrition 15 (1995): 473–493.

Khazan, O. «When Trans Fats Were Healthy,» The Atlantic , November 8, 2013.

Kolata, G. «Mediterranean Diet Shown to Ward Off Heart Attack and Stroke,» New York Times , February 25, 2013.

Lemaitre, R. N., I. B. King, T. E. Raghunathan, et al. «Cell Membrane Trans -Fatty Acids and the Risk of Primary Cardiac Arrest,» Circulation 105 (2002): 697–701.